Cargando…
Hyperandrogenism and menstrual imbalance are the best predictors of metformin response in PCOS patients
BACKGROUND: Moving from the correlation between insulin-resistance and PCOS, metformin has been administered in some PCOS women improving ovulatory and metabolic functions and decreasing androgen levels. Inconsistency and unpredictability of response to metformin limit its extensive use. Aim of this...
Autores principales: | Garzia, Emanuele, Galiano, Valentina, Marfia, Giovanni, Navone, Stefania, Grossi, Enzo, Marconi, Anna Maria |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8729102/ https://www.ncbi.nlm.nih.gov/pubmed/34983571 http://dx.doi.org/10.1186/s12958-021-00876-0 |
Ejemplares similares
-
Prevalence of Metabolic Syndrome Is Higher among Non-Obese PCOS Women with Hyperandrogenism and Menstrual Irregularity in Korea
por: Kim, Min-Ju, et al.
Publicado: (2014) -
Effects of Metformin as Add-On Therapy against Glioblastoma: An Old Medicine for Novel Oncology Therapeutics
por: Guarnaccia, Laura, et al.
Publicado: (2022) -
Frontiers in Anti-Cancer Drug Discovery: Challenges and Perspectives of Metformin as Anti-Angiogenic Add-On Therapy in Glioblastoma
por: Guarnaccia, Laura, et al.
Publicado: (2021) -
Hyperandrogenism Does Not Influence Metabolic Parameters in Adolescent Girls with PCOS
por: Forrester-Dumont, Kim, et al.
Publicado: (2012) -
Sustained Maternal Hyperandrogenism During PCOS Pregnancy Reduced by Metformin in Non-obese Women Carrying a Male Fetus
por: Andræ, Frida, et al.
Publicado: (2020)